Thompson Street Capital-backed LifeSpan Biosciences to acquire Absolute Antibody.

Thompson Street Capital Partners-backed LifeSpan Biosciences, a biotechnology company, agreed to acquire Absolute Antibody, a manufacturer of recombinant antibodies. Financial terms were not disclosed. “We’re excited to be partnering with the founders and management team of Absolute Antibody. The Company highly complements our existing efforts in life science reagents through our platform LSBio," Bob Dunn, TSCP Managing Partner.